RFK Jr. Wants Thimerosal Removed from US Vaccines
CDC Advisory Panel Votes to Remove Thimerosal from All Vaccines
A Controversial Decision with Global Implications
In a move that has sent ripples through the public health community, a key advisory panel to the Centers for Disease Control and Prevention (CDC) has voted to recommend the removal of thimerosal, a mercury-containing preservative, from all vaccines administered in the United States. The decision, which passed with a 5-1 vote and one abstention, follows a contentious presentation by Lyn Redwood, a prominent figure in the anti-vaccine movement and former leader of the World Mercury Project, the precursor to Robert F. Kennedy Jr.’s Children’s Health Defense.
The vote and Its Context
The vaccine advisory panel’s vote to remove thimerosal marks a meaningful shift, particularly given the context of the presentation that preceded it. Redwood’s advocacy against thimerosal has been a long-standing point of contention, with many public health organizations asserting its safety and necessity in multi-dose vaccine vials to prevent bacterial contamination.
The presentation itself was not without controversy. it was revealed that Redwood’s submission included a link to a study that, upon closer inspection, did not exist. Moreover, a career scientist from the CDC, who was slated to present data supporting the safety of thimerosal, reportedly had their presentation pulled by the secretary’s office. This sequence of events has raised questions about the transparency and scientific rigor of the review process.
The Role of Robert F. Kennedy Jr.
Adding another layer of complexity to this decision is the involvement of Robert F. Kennedy Jr., who currently heads the CDC in the absence of a Senate-confirmed director. The director of the CDC is tasked with signing off on the recommendations made by the vaccine advisory committee. This means that Kennedy, a vocal critic of vaccines and a proponent of the idea that they cause autism, holds significant influence over this critical public health policy.
Kennedy has been a vocal advocate for the removal of thimerosal, often citing concerns about mercury exposure in children. His stance has been met with strong opposition from many medical and scientific bodies, which maintain that the amount of thimerosal used in vaccines is safe and that its removal could pose risks, particularly in the context of maintaining vaccine sterility in multi-dose vials.
Global ramifications
The decision by the US advisory panel to recommend the removal of thimerosal from all vaccines is highly likely to have significant implications beyond American borders. vaccine manufacturers operate on a global scale, and a change in US policy could influence international standards and practices.”With the US now removing mercury from all vaccines, we urge global health authorities to follow this prudent example for the protection of children worldwide,” Kennedy stated following the vote. This call to action highlights the potential for this decision to set a precedent for other countries, potentially impacting global vaccine supply chains and public health strategies.
The Thimerosal Debate: A Brief Overview
Thimerosal, an ethylmercury-containing preservative, was introduced into vaccines in the 1930s to prevent bacterial and fungal contamination in multi-dose vials. For decades, it was a standard component in many vaccines. However, concerns about mercury exposure, particularly in relation to neurodevelopmental disorders like autism, began to surface in the late 1990s.
Numerous large-scale scientific studies conducted by reputable health organizations, including the CDC, the World Health Organization (WHO), and the Institute of Medicine (now the National academy of Medicine), have consistently found no link between thimerosal in vaccines and autism or other developmental disorders. These studies have concluded that the ethylmercury in thimerosal is cleared from the body much more rapidly than methylmercury, the type found in fish, and does not accumulate to harmful levels.
Despite the scientific consensus, the debate surrounding thimerosal has persisted, fueled by advocacy groups and a segment of the public concerned about vaccine safety. The recent vote by the CDC advisory panel appears to reflect a shift in policy, driven by these ongoing concerns, even as the scientific community largely maintains that thimerosal is safe when used in vaccines.
Looking Ahead
The recommendation from the advisory panel is a significant step, but it is not the final word. The ultimate decision rests with the
